Regulus Arcturus Black
Full Member
Germany reporting that EU-commission has refused to approve AZ for over 65’s? Bit mad that, gives only 10% protection for that group according to those reports.
Germany reporting that EU-commission has refused to approve AZ for over 65’s? Bit mad that, gives only 10% protection for that group according to those reports.
Has to be rubbish.
Sounds utterly bizarre, 8% according to another German source.
https://www.reuters.com/article/hea...a-vaccine-for-seniors-bild-says-idUSL1N2K024E
Sounds utterly bizarre, 8% according to another German source.
https://www.reuters.com/article/hea...a-vaccine-for-seniors-bild-says-idUSL1N2K024E
I hope this is shown up to be nonsense very quickly, as it could utterly undermine the vaccine rollout in the UK if this blows up.
The source is Bild. It’s the German version of the Sun and they’re refusing to name sources or supply any data. They also demanded on their front page recently to know why a Cypriot was running the EMA vaccine procurement program.
Best to remain sceptical at this point.
Oh I’m sceptical, hence saying it seems utterly bizarre. Even as a nonsense story it’s an odd one.
Just looking back at the Lancet publication (that’s how exciting my life is these days) Only 418 out of the 11600 subjects in the primary analysis were aged 70+. So was always going to be a stretch to be confident it works in elderly.
Likely that EMA got data cuts that weren’t available at time of MHRA submission. Assuming still very small numbers of >70yo would only take a few cases of covid in the vaccine arm to completely undermine efficacy data submitted in UK. If that’s the case then the MHRA will have to amend Uk license.
Interesting few days ahead!
Should also say, re-reading the Lancet paper reminded me what an absolute fecking shambles it was. I still think/hope it’s a decent vaccine but they made an awful bollix of proving it. On the plus side, there’s more data being generated all the time. So at some point there will be really solid evidence to work through.
My thoughts from the other thread.
Telegraph front-page is the EU are threatening to block Pfizer exports to the UK from Brussels because of the cut in AZ supply. It’s all politics unfortunately.Surely there is no coicedence that this is coming out after the reported heated meetings between the EU and AZ today, I'm not saying there's not holes in the data, but would it have been reported like this if AZ were on track with all their promised delveries.
My sister in law works for J&J (in a role that isn't specifically vaccine related but which touches on it) and the noises from within are very positive, at least.Johnson & Johnson vaccine sounds really promising.
Would make sense for any manufacturer to concentrate on producing a one shot high efficacy vaccine rather than some of the 2 dose ones. Sub contract it out. Why have a manufacturer waste time and similar resources in a pandemic making the worst 2 dose vaccine later on? It's obviously also double the work administering the jabs and adds months extra in limbo for full protection, that's months more restrictions having a huge impact on economies and peoples patience around the world.
Not sure on the exact materials on the AZ compared to J&J etc. AZ is useful right now given UK's dire situation and has been touted as a good one for third world countries due to storage but the 2 dose Moderna one is there now. The time and work giving out 2 doses is tough for anywhere so might make sense to go all out on J&J and Moderna later? As awareness grows you could have more wanting the high efficacy vaccines so a lot of effort could go to waste later in the year unless they phase some out.
Surely there is no coicedence that this is coming out after the reported heated meetings between the EU and AZ today, I'm not saying there's not holes in the data, but would it have been reported like this if AZ were on track with all their promised deliveries.
Telegraph front-page is the EU are threatening to block Pfizer exports to the UK from Brussels because of the cut in AZ supply. It’s all politics unfortunately.
My sister in law works for J&J (in a role that isn't specifically vaccine related but which touches on it) and the noises from within are very positive, at least.
Yeah. I think she said it may ship in April, all going well. The two options of delivery temperature (2-8 for 3 months shelf life and -20 for 2 years) seems to be seen as a really positive thing with the lower income countries in mind, particularly.I’ve heard similar noises. Here’s hoping this one’s a legit blockbuster. We’re due some good news!
Yeah. I think she said it may ship in April, all going well. The two options of delivery temperature (2-8 for 3 months shelf life and -20 for 2 years) seems to be seen as a really positive thing with the lower income countries in mind, particularly.
Was this post picked up?Its worst effectiveness data would have been good enough though. Obviously, we would all like to get a vaccine that is 95% effective but I'd take the Oxford one in a flash if it were the one on offer.
It might be the only one we have in AU. It looks like we were so late to the party ordering others that need importing that the Oxford one, which will be made here, may be the first cab off the rank and the only one for some time. We are only now thinking about ordering the Johnson and Johnson one - which could be good new if it is as effective as the rumors say - 100% and sterilising.
Oxford vaccine report wrong unsurprisingly.
https://amp.abc.net.au/article/13091806
I clicked the Spiegel link.. couldnt find what that data was based on..
I am guessing AZ submitted data for 2 full doses (the one that supposedly had 62% efficacy) .. and breaking it down by age groups, the efficacy for ages over 65 was 8%..
Is that what it is? If so, I can see why there would be concerns.. totally understandable.
Its been over a month since those numbers were announced.. they are running a huge phase 3 trial.. surely they have a much large data set now.. If it shows the vaccine works well over 65.. they will just publish the new data.
“Wrong” according to the manufacturer. So possibly not wrong at all.
Oxford vaccine report wrong unsurprisingly.
https://amp.abc.net.au/article/13091806
“Wrong” according to the manufacturer. So possibly not wrong at all.
Was this post picked up?
Maybe but would you trust unsubstantiated rumours from the German equivalent of The Sun?
I think it is very unlikely 8% is anywhere near correct. Older people typically only get slightly less benefit from vaccination so such a huge drop off would be unusul. Plus the data we do have suggests the efficiency is pretty damn good for older people.
Eh? Do you mean something different by sterilisation?Wouldn't this be great news if phase 3 trials confirm it?
The article I read was a summary of a story in Handelsblatt, not Bild.
Here’s a tweet thread from one of the journalists involved.
Eh? Do you mean something different by sterilisation?
That's a nightmare performance by Bild if that's the case.
According to data from the Financial Times and Duke University, the EU is among the biggest purchasers of the J&J/Janssen jab, well ahead of orders form the US, the UK and elsewhere.
It's a sensible gamble, the J&J jab will prove an absolute game changer with its single dose regimen if it survives the clinical trials gauntlet (which fingers crossed it looks like its on track to). It means EU countries won't have to make excruciating decisions on delaying a second dose if they can just 'one and done' folks. The issue is supply and of course if its effective.Link.
This pleases me. Finally the EU might have made the right call.
Now watch the fecking J&J jab fail!